| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 18 |
| 1 | ASPIRIN | 9 |
| 2 | ASPIRIN 325 MG | 9 |
| 3 | ASPIRIN 81 MG | 9 |
| 4 | PANTOPRAZOLE SODIUM | 8 |
| 5 | AMLODIPINE | 7 |
| 6 | ERGOCALCIFEROL | 7 |
| 7 | GABAPENTIN | 6 |
| 8 | ACETAMINOPHEN | 5 |
| 9 | CISPLATIN | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | POTASSIUM CHLORIDE AND SODIUM CHLORIDE | 1 | 0.0167 |
| 1 | DELANDISTROGENE MOXEPARVOVEC-ROKL | 1 | 0.0027 |
| 2 | ACYCLOVIR SODIUM | 3 | 0.0024 |
| 3 | RESLIZUMAB | 1 | 0.0015 |
| 4 | TIVOZANIB | 2 | 0.0012 |
| 5 | PSYLLIUM HUSK | 1 | 0.0007 |
| 6 | CLEMASTINE FUMARATE | 1 | 0.0007 |
| 7 | VINORELBINE | 4 | 0.0006 |
| 8 | VAMOROLONE | 1 | 0.0006 |
| 9 | CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE | 1 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] | 1 | 0.0003 |
| 2 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |
| 3 | Ergot Derivative [EPC] | 1 | 0.0002 |
| 4 | Calcitonin Gene-related Peptide Antagonist [EPC] | 1 | 0.0001 |
| 5 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1 | 0.0001 |
| 6 | BCL-2 Inhibitor [EPC] | 5 | 0.0001 |
| 7 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 1 | 0.0001 |
| 8 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 1 | 0.0001 |
| 9 | GLP-2 Analog [EPC] | 1 | 0.0001 |